Patents Assigned to Imarx Therapeutics, Inc.
  • NON-INVASIVE METHODS FOR SURGERY IN THE VASCULATURE
    Publication number: 20030088176
    Abstract: Novel methods of non-invasive intravascular surgery are disclosed.
    Type: Application
    Filed: May 10, 2001
    Publication date: May 8, 2003
    Applicant: ImaRx Therapeutics, Inc.
    Inventor: Evan C. Unger
  • Oxygen delivery agents and uses for the same
    Patent number: 6537246
    Abstract: The present invention describes, inter alia, oxygen delivery agents or blood substitutes comprising a fluorinated gas and a stabilizing material, uses for the oxygen delivery agents or blood substitutes, and apparatus for making and delivering the oxygen delivery agents or blood substitutes.
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: March 25, 2003
    Assignee: IMARX Therapeutics, Inc.
    Inventors: Evan C. Unger, Thomas McCreery, Yunqiu Wu
  • Charged lipids and uses for the same
    Publication number: 20030054027
    Abstract: The present invention is directed to charged lipids, compositions comprising charged lipids, and the use of these compositions in drug delivery, targeted drug delivery, therapeutic imaging and diagnostic imaging, as well as their use as contrast agents.
    Type: Application
    Filed: January 15, 2002
    Publication date: March 20, 2003
    Applicant: ImaRx Therapeutics, Inc.
    Inventor: Evan C. Unger
  • Method of magnetic resonance focused surgical and therapeutic ultrasound
    Patent number: 6461586
    Abstract: A novel method for the controlled delivery of therapeutic compounds to a region of a patient, using magnetic resonance focused therapeutic ultrasound, is disclosed.
    Type: Grant
    Filed: July 10, 2000
    Date of Patent: October 8, 2002
    Assignee: Imarx Therapeutics, Inc.
    Inventor: Evan C. Unger
  • Lipid soluble steroid prodrugs
    Patent number: 6444660
    Abstract: The present invention is directed to novel lipid soluble steroid prodrugs, compositions comprising steroid prodrugs, and uses of the same.
    Type: Grant
    Filed: February 3, 2000
    Date of Patent: September 3, 2002
    Assignee: Imarx Therapeutics, Inc.
    Inventors: Evan C. Unger, DeKang Shen
  • Silicon amphiphilic compounds and the use thereof
    Patent number: 6414139
    Abstract: Novel silicon amphiphilic compounds which comprise a silicon residue. The silicon amphiphilic compounds are particularly suitable for use in compositions for diagnostic imaging, such as ultrasound. Compositions of the silicon amphiphilic compounds comprise a gas or gaseous precursor, and may take the form of vesicle compositions, such as micelles or liposomes.
    Type: Grant
    Filed: September 3, 1996
    Date of Patent: July 2, 2002
    Assignee: Imarx Therapeutics, Inc.
    Inventors: Evan C. Unger, Dekang Shen, Guanli Wu
  • Method for delivering bioactive agents using cochleates
    Patent number: 6403056
    Abstract: The present invention is directed to charged lipids, compositions comprising charged lipids, and the use of these compositions in drug delivery, targeted drug delivery, therapeutic imaging and diagnostic imaging, as well as their use as contrast agents.
    Type: Grant
    Filed: March 31, 2000
    Date of Patent: June 11, 2002
    Assignee: Imarx Therapeutics, Inc.
    Inventor: Evan C. Unger
  • Gas filled microspheres as magnetic resonance imaging contrast agents
    Patent number: 6315981
    Abstract: Novel gas filled microspheres useful as magnetic resonance imaging (MRI) contrast agents are provided.
    Type: Grant
    Filed: March 19, 1999
    Date of Patent: November 13, 2001
    Assignee: Imarx Therapeutics, Inc.
    Inventor: Evan C. Unger
  • Solid matrix therapeutic compositions
    Publication number: 20010018072
    Abstract: The present invention is directed to a solid porous matrix comprising a surfactant in combination with a bioactive agent. The solid porous matrix may be prepared by combining a surfactant and a therapeutic, together with a solvent, to form an emulsion containing random aggregates of the surfactant and the therapeutic, and processing the emulsion by controlled drying, or controlled agitation and controlled drying to form the solid porous matrix.
    Type: Application
    Filed: April 9, 2001
    Publication date: August 30, 2001
    Applicant: ImaRx Therapeutics, Inc.
    Inventor: Evan C. Unger